FGF23 or PTH: which comes first in CKD ?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21030968.
- Also identified by DOI 10.1038/ki.2010.281.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the past 40 years, disordered mineral metabolism has been among the most intensely studied areas of nephrology. A June 2010 PubMed search for 'secondary hyperparathyroidism and kidney disease' yielded 5866 references. Among these are papers documenting the development and application of numerous therapeutic agents-including calcitriol, vitamin D analogs, phosphate binders, and cinacalcet-that remain in widespread use in the day-to-day management of dialysis patients worldwide. However, almost 6000 papers later, fundamental pathophysiological concepts remain unclear, particularly regarding the early pathogenesis of disordered mineral metabolism.
Medical subject headings
- Fibroblast Growth Factors
- Kidney Diseases
- Parathyroid Hormone